ARTICLE
5 April 2021

Webinar Recording: AI In Life Sciences - Patenting Dos And Don'ts

MS
Mathys & Squire

Contributor

We believe that effective systems for protecting intellectual property (IP) are essential so that innovators can be properly rewarded. Our clients become successful by recognising the opportunities and risks of IP and following a well thought out IP strategy.

We become part of that success by developing excellence; instilling a culture of creativity, innovation and adding value for all our clients.

Founded in 1910, we have over 100 years of experience in the protection and commercialisation of intellectual property rights, leading the field with insight, innovation and quality. Highly ranked in key legal directories The Legal 500 and Chambers & Partners, as well as IP directories IAM 1000 and World Trade Mark Review 1000, Mathys & Squire is Europe’s premier intellectual property firm.

Artificial intelligence is transforming the life sciences industry, finding applications everywhere from drug discovery to medical diagnosis.
United Kingdom Intellectual Property

Artificial intelligence is transforming the life sciences industry, finding applications everywhere from drug discovery to medical diagnosis. But how do inventions in this grey area between traditional subjects fit into the patent system? 

In this webinar, Jeremy Smith and Alexander Robinson take a look at the European Patent Office's approach to this developing field of technology, including an overview of the fundamentals of AI together with case studies highlighting important issues for life sciences AI inventions in particular.

Click here to watch the recording

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More